Clinical Trial Update: Neoadjuvant Combination Immunotherapy for Stage III Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant immunotherapy trial for stage III melanoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: University of Louisville | Conditions: Cutaneous Melanoma | Phase 2 | Status: RECRUITING